Concepedia

Publication | Open Access

Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact

131

Citations

43

References

2017

Year

Abstract

Key Points MYC and BCL2 genetic alterations are associated with COO subtype-specific clinical effect in R-CHOP-treated DLBCL.

References

YearCitations

Page 1